Kantar Health is a leading provider of proprietary, patient-centric data to the pharmaceutical and healthcare industries.
Our data cover 190 conditions in both established and emerging markets.
Accurately identify and screen promising global oncology targets
Invaluable and comprehensive tool providing market analysis, strategic planning and identification of commercial opportunities
Comprehensive database of physicians who influence their peers’ cancer treatment decisions
Most trusted industry resource providing reliable, rigorous research and documentation for G7 and emerging countries
Providing the blueprints for a defendable forecast in the pharmaceutical market
Rigorous patient-reported data, with national projections to deliver patient insight
Stakeholder insights for developing value propositions that create enduring product access
Analyzes critical reimbursement, coverage and competitive issues in the EU oncology landscape